https://dev.intervacc.se/kallelse-extra-bolagsstamma/ 2017-01-26T15:55:43+00:00 https://dev.intervacc.se/nyemissionen-overtecknad/ 2017-01-26T16:12:20+00:00 https://dev.intervacc.se/intervacc-genomfor-kombinerad-foretrades-och-riktad-emission/ 2017-01-26T16:22:06+00:00 https://dev.intervacc.se/gladjande-resultat-strangvacs-finala-studier/ 2017-01-26T22:33:13+00:00 https://dev.intervacc.se/patent-usa-beviljat-nytt-vaccin-mot-kvarka/ 2017-01-26T23:25:51+00:00 https://dev.intervacc.se/strangvac-clinical-trials-confirm-expected-efficacy/ 2017-02-17T12:37:38+00:00 https://dev.intervacc.se/nyemissionen-overtecknad-eng/ 2017-02-17T12:38:17+00:00 https://dev.intervacc.se/animal-pharm-skriver-om-kvarka-och-strangvac/ 2017-02-20T00:25:30+00:00 https://dev.intervacc.se/wp-content/uploads/2017/02/animalpharm_logo.jpg https://dev.intervacc.se/intervacc-tecknar-avtal-om-processoptimering/ 2017-02-20T14:20:54+00:00 https://dev.intervacc.se/wp-content/uploads/2017/02/logo_pxt.png https://dev.intervacc.se/wp-content/uploads/2017/02/aguettant.png https://dev.intervacc.se/intervacc-signs-agreement-optimization-manufacturing/ 2017-02-20T14:21:16+00:00 https://dev.intervacc.se/wp-content/uploads/2017/02/logo_pxt.png https://dev.intervacc.se/wp-content/uploads/2017/02/aguettant.png https://dev.intervacc.se/intervacc-ab-publ-acquires-nordvacc/ 2017-02-22T15:42:30+00:00 https://dev.intervacc.se/intervacc-publ-forvarvar-nordvacc/ 2017-02-22T15:54:21+00:00 https://dev.intervacc.se/intervacc-ab-publ-bjuder-till-investerarpresentationer-infor-listning-pa-nasdaq-first-north/ 2017-03-01T10:30:16+00:00 https://dev.intervacc.se/intervacc-bevakas-nu-pa-introduce-se/ 2017-03-07T17:46:47+00:00 https://dev.intervacc.se/wp-content/uploads/2017/03/remium-introduce.png https://dev.intervacc.se/intervacc-now-introduce-se/ 2017-03-07T18:35:29+00:00 https://dev.intervacc.se/wp-content/uploads/2017/03/remium-introduce.png https://dev.intervacc.se/erbjudandet-att-teckna-units-overtecknades/ 2017-03-20T16:00:07+00:00 https://dev.intervacc.se/intervacc-ab-publ-ar-godkant-listning-pa-nasdaq-first-north/ 2017-04-04T14:18:22+00:00 https://dev.intervacc.se/intervacc-ab-publ-offentliggor-prospekt-avseende-nyemission-av-units-infor-listning-pa-nasdaq-first-north/ 2017-04-10T16:19:14+00:00 https://dev.intervacc.se/vd-jan-ingmar-flock-gast-pa-trading-direkt/ 2017-04-12T08:34:51+00:00 https://dev.intervacc.se/wp-content/uploads/2017/04/Direkt-170410-omslag.jpg https://dev.intervacc.se/intervacc-ab-publ-publicerar-arsredovisning-2016/ 2017-04-26T15:52:39+00:00 https://dev.intervacc.se/intervacc-presented-results-clinical-trials-weas-2017/ 2017-08-01T22:40:47+00:00 https://dev.intervacc.se/wp-content/uploads/2017/08/WEAS_log.png https://dev.intervacc.se/intervacc-presented-results-clinical-trials-scientific-meeting-strangles/ 2017-09-25T22:30:25+00:00 https://dev.intervacc.se/intervacc-ab-enters-into-a-commercial-production-phase-with-strangvac/ 2017-10-19T07:50:00+00:00 https://dev.intervacc.se/metodpatent-for-kvarkavaccinet-strangvac-i-usa/ 2017-10-19T13:20:09+00:00 https://dev.intervacc.se/delarsrapport-intervacc-ab-januari-juni-2017/ 2017-10-19T13:20:09+00:00 https://dev.intervacc.se/kommunike-fran-arsstamma-i-intervacc-ab-publ/ 2017-10-19T13:20:10+00:00 https://dev.intervacc.se/lanserar-tre-nya-djurlakemedel-i-sverige/ 2017-10-19T13:20:10+00:00 https://dev.intervacc.se/intervacc-inleder-nasta-steg-i-utvecklingen-av-ett-vaccin-mot-streptokock-infektion-pa-smagris/ 2017-10-19T13:20:10+00:00 https://dev.intervacc.se/kallelse-till-arsstamma-i-intervacc-ab-publ/ 2017-10-19T13:20:11+00:00 https://dev.intervacc.se/delarsrapport-1-januari-31-mars-2017/ 2017-10-19T13:20:11+00:00 https://dev.intervacc.se/intervacc-ab-gar-in-i-kommersiell-produktionsfas-med-sitt-nya-vaccin-strangvac/ 2017-10-19T13:20:34+00:00 https://dev.intervacc.se/fortydligande-avseende-pressmeddelande-om-att-intervacc-gar-in-i-kommersiell-produktionsfas/ 2017-10-19T13:23:04+00:00 https://dev.intervacc.se/lovande-resultat-fran-studie-av-vaccin-mot-streptokockinfektion-pa-gris/ 2017-11-21T10:35:47+00:00 https://dev.intervacc.se/lunchpresentation-med-intervaccs-vd/ 2017-11-22T15:45:31+00:00 https://dev.intervacc.se/delarsrapport-intervacc-ab-januari-september-2017/ 2017-12-04T11:46:10+00:00 https://dev.intervacc.se/styrelsemedlem-avgar-pa-egen-begaran-fran-intervaccs-styrelse/ 2018-01-04T07:41:44+00:00 https://dev.intervacc.se/significant-progress-has-been-made-in-the-development-of-a-new-vaccine-against-staphylococcus-aureus-infections/ 2018-01-10T07:30:00+00:00 https://dev.intervacc.se/viktiga-framsteg-har-gjorts-for-utvecklingen-av-ett-nytt-vaccin-mot-infektioner-orsakade-av-staphylococcus-aureus/ 2018-01-10T07:43:24+00:00 https://dev.intervacc.se/intervacc-medverkar-pa-investerardagen-19-januari/ 2018-01-11T16:01:47+00:00 https://dev.intervacc.se/intervacc-completes-manufacturing-agreement-for-new-vaccine-against-equine-strangles/ 2018-01-30T07:30:00+00:00 https://dev.intervacc.se/intervacc-completes-manufacturing-agreement-for-new-vaccine-against-equine-strangles/ 2018-01-30T07:30:00+00:00 https://dev.intervacc.se/avtal-med-tillverkare-av-nytt-kvarkavaccin-nu-slutfort/ 2018-02-01T15:22:25+00:00 https://dev.intervacc.se/aht-om-strangvac-ett-extremt-intressant-vaccin/ 2018-02-07T23:23:44+00:00 https://dev.intervacc.se/icons/twitter.svg https://dev.intervacc.se/kvarka-uppmarksammat-reportage-av-sveriges-radio/ 2018-02-07T23:30:24+00:00 https://dev.intervacc.se/icons/twitter.svg https://dev.intervacc.se/andrat-datum-for-offentliggorande-av-bokslutskommunike-2017/ 2018-02-09T11:47:56+00:00 https://dev.intervacc.se/icons/twitter.svg https://dev.intervacc.se/bokslutskommunike-2017-intervacc-ab/ 2018-02-15T08:02:40+00:00 https://dev.intervacc.se/icons/twitter.svg https://dev.intervacc.se/intervacc-medverkar-pa-aktiespararnas-aktiekvall-i-stockholm/ 2018-02-16T09:54:07+00:00 https://dev.intervacc.se/intervacc-ab-offentliggor-foretradesemission-om-cirka-61-msek-infor-storskalig-gmp-tillverkning-av-strangvac-2/ 2018-02-18T17:00:00+00:00 https://dev.intervacc.se/intervacc-ab-offentliggor-foretradesemission-om-cirka-61-msek-infor-storskalig-gmp-tillverkning-av-strangvac-2/ 2018-02-18T17:00:00+00:00 https://dev.intervacc.se/intervacc-ab-offentliggor-foretradesemission-om-cirka-61-msek-infor-storskalig-gmp-tillverkning-av-strangvac-2/ 2018-02-18T17:00:00+00:00 https://dev.intervacc.se/intervacc-ab-offentliggor-foretradesemission-om-cirka-61-msek-infor-storskalig-gmp-tillverkning-av-strangvac/ 2018-02-18T17:00:00+00:00 https://dev.intervacc.se/kallelse-till-extra-bolagsstamma-i-intervacc-ab-publ/ 2018-02-19T12:30:00+00:00 https://dev.intervacc.se/kommunike-fran-extra-bolagsstamma-i-intervacc-ab-publ-2/ 2018-03-09T15:00:00+00:00 https://dev.intervacc.se/kommunike-fran-extra-bolagsstamma-i-intervacc-ab-publ/ 2018-03-09T15:40:56+00:00 https://dev.intervacc.se/nordvaccs-avtal-med-tillverkare-av-minkvaccin-uppsagt-i-sin-nuvarande-form-intervacc-avser-att-omforhandla-avtalet-med-mal-om-battre-villkor/ 2018-03-13T11:03:39+00:00 https://dev.intervacc.se/intervacc-ab-publ-offentliggor-prospekt-avseende-nyemission-av-aktier/ 2018-03-13T19:12:04+00:00 https://dev.intervacc.se/inbjudan-till-intervaccs-bolagspresentationer/ 2018-03-14T10:02:57+00:00 https://dev.intervacc.se/intervacc-ab-publ-insynspersoner-overlater-teckningsratter-vederlagsfritt/ 2018-03-28T10:30:48+00:00 https://dev.intervacc.se/intervacc-vaxer-och-soker-cmc-manager/ 2018-03-29T08:24:05+00:00 https://dev.intervacc.se/wp-content/uploads/2018/03/dfind.png https://dev.intervacc.se/intervacc-rights-issue-oversubscribed/ 2018-04-13T14:21:24+00:00 https://dev.intervacc.se/intervacc-ab-publ-publicerar-arsredovisning-for-2017/ 2018-04-24T19:27:16+00:00 https://dev.intervacc.se/nytt-datum-for-arsstamma-i-intervacc-ab-publ/ 2018-04-25T06:32:31+00:00 https://dev.intervacc.se/intervacc-ab-sista-dag-for-handel-med-bta/ 2018-05-02T12:32:08+00:00 https://dev.intervacc.se/intervacc-beviljas-medel-fran-vinnova-for-att-utveckla-ett-nytt-vaccin/ 2018-05-24T09:03:06+00:00 https://dev.intervacc.se/nordvaccs-samarbete-med-tillverkaren-idt-biologika-kommer-inte-att-fornyas/ 2018-05-24T22:02:05+00:00 https://dev.intervacc.se/delarsrapport-intervacc-ab-januari-mars-2018/ 2018-05-25T06:35:17+00:00 https://dev.intervacc.se/intervacc-ab-nomination-committees-proposal-for-board-of-directors-for-the-2018-annual-general-meeting/ 2018-06-01T08:48:36+00:00 https://dev.intervacc.se/valberedningens-forslag-till-styrelse-och-ordforande-i-intervacc-ab-publ/ 2018-06-11T22:28:11+00:00 https://dev.intervacc.se/kommunike-fran-arsstamma-i-intervacc-ab-publ-2/ 2018-06-14T15:40:11+00:00 https://dev.intervacc.se/kallelse-till-arsstamma-i-intervacc-ab-publ-2/ 2018-06-28T08:08:21+00:00 https://dev.intervacc.se/intervacc-ab-byter-certified-adviser-till-eminova-fondkommission-ab/ 2018-06-29T14:05:20+00:00 https://dev.intervacc.se/intervacc-tecknar-avtal-om-framtida-fyllning-och-frislappning-av-strangvac/ 2018-07-09T11:00:59+00:00 https://dev.intervacc.se/intervacc-signs-an-agreement-for-future-filling-and-release-of-strangvac/ 2018-07-09T11:01:29+00:00 https://dev.intervacc.se/intervacc-recieves-funding-from-eurostars-for-further-development-of-vaccine-for-piglets/ 2018-07-12T06:58:29+00:00 https://dev.intervacc.se/intervacc-beviljas-eurostars-finansiering-for-vidareutveckling-av-vaccin-till-gris/ 2018-07-12T07:00:47+00:00 https://dev.intervacc.se/intervaccs-team-for-en-ny-generation-vacciner-vaxer/ 2018-08-15T14:02:38+00:00 https://dev.intervacc.se/intervacc-presenterar-pa-investerardagen-27-augusti/ 2018-08-20T13:16:11+00:00 https://dev.intervacc.se/delarsrapport-intervacc-ab-januari-juni-2018/ 2018-08-30T06:31:41+00:00 https://dev.intervacc.se/ny-kompletterande-strangvac-studie-pavisar-immunologiskt-minne-under-lang-tid/ 2018-10-15T06:30:57+00:00 https://dev.intervacc.se/new-supplementary-strangvac-study-demonstrates-immunological-memory-with-long-duration/ 2018-10-15T06:31:11+00:00 https://dev.intervacc.se/intervacc-vaxer-och-soker-driven-lakemedelsutvecklare/ 2018-10-30T15:30:34+00:00 https://dev.intervacc.se/wp-content/uploads/2018/10/Search4S.png https://dev.intervacc.se/delarsrapport-intervacc-ab-januari-september-2018/ 2018-11-29T07:30:30+00:00 https://dev.intervacc.se/mot-intervacc-pa-introduce-investor-day/ 2018-12-03T22:58:22+00:00 https://dev.intervacc.se/ny-vd-i-innovativa-och-vaxande-vaccinbolaget-intervacc/ 2018-12-12T07:31:14+00:00 https://dev.intervacc.se/new-ceo-appointed-for-intervacc-a-innovative-and-expanding-vaccine-company/ 2018-12-12T07:31:57+00:00 https://dev.intervacc.se/bokslutskommunike-2018-intervacc-ab/ 2019-02-22T07:31:24+00:00 https://dev.intervacc.se/storskalig-tillverkningsprocess-for-strangvac-nu-sakerstalld/ 2019-04-01T09:13:13+00:00 https://dev.intervacc.se/uppdatering-kontaktuppgifter-till-certified-adviser-storskalig-tillverkningsprocess-for-strangvac-nu-sakerstalld/ 2019-04-01T13:18:38+00:00 https://dev.intervacc.se/update-of-contact-information-for-certified-adviser-for-previous-press-release-large-scale-manufacturing-process-for-strangvac-now-secured/ 2019-04-01T13:26:17+00:00 https://dev.intervacc.se/delarsrapport-intervacc-januari-mars-2019/ 2019-05-29T06:41:04+00:00 https://dev.intervacc.se/intervacc-ab-and-the-swedish-university-of-agricultural-sciences-slu-sign-a-multi-year-contract-for-the-development-of-innovative-animal-health-vaccines/ 2019-06-11T07:04:34+00:00 https://dev.intervacc.se/kommunike-fran-arsstamma-i-intervacc-ab-publ-3/ 2019-06-11T17:01:31+00:00 https://dev.intervacc.se/kallelse-till-arsstamma-i-intervacc-ab-publ-3/ 2019-06-17T11:42:38+00:00 https://dev.intervacc.se/the-manufacturing-process-for-strangvac-is-proceeding-according-to-plan/ 2019-08-07T07:36:53+00:00 https://dev.intervacc.se/aktietraff-den-30-januari/ 2019-08-28T07:18:53+00:00 https://dev.intervacc.se/intervacc-medverkar-pa-introduce-investor-days-3-september/ 2019-09-04T12:08:07+00:00 https://dev.intervacc.se/delarsrapport-intervacc-januari-juni-2019/ 2019-09-25T14:43:48+00:00 https://dev.intervacc.se/uppdaterad-tidsplan-for-inlamnandet-av-ansokan-till-europeiska-lakemedelsverket/ 2019-11-12T15:57:08+00:00 https://dev.intervacc.se/debattartikel-i-svd-vaccin-till-djur-kan-minska-antibiotika/ 2019-11-18T11:22:22+00:00 https://dev.intervacc.se/wp-content/uploads/2018/11/Jan-Ingmar_Flock_strangvac_sm1.jpg https://dev.intervacc.se/intervacc-medverkar-pa-introduce-investor-days-den-5-december/ 2019-11-21T14:18:44+00:00 https://dev.intervacc.se/validation-batches-of-strangvac-completed/ 2019-11-25T20:44:52+00:00 https://dev.intervacc.se/delarsrapport-januari-september-2019/ 2019-11-28T07:30:55+00:00 https://dev.intervacc.se/stor-potential-for-svensk-djurhalsoaktie/ 2020-01-13T14:00:03+00:00 https://dev.intervacc.se/icons/twitter.svg https://dev.intervacc.se/intervacc-och-sveriges-lantbruksuniversitet-slu-tecknar-flerarigt-samarbetsavtal-for-vidareutveckling-av-en-ny-generation-vacciner-inom-djurhalsa/ 2020-02-05T23:47:38+00:00 https://dev.intervacc.se/intervacc-appoints-new-cfo-and-new-vp-supply-chain-management/ 2020-02-06T13:41:08+00:00 https://dev.intervacc.se/intervacc-utser-ny-cfo-samt-ny-logistik-och-inkopschef/ 2020-02-06T13:44:08+00:00 https://dev.intervacc.se/intervacc-utokar-distributionsavtalet-med-animalcare-group-plc/ 2020-02-06T19:35:21+00:00 https://dev.intervacc.se/debattartikel-i-sydsvenskan-antibiotikaresistens-ar-pa-vag-att-bli-ett-av-de-allvarligaste-hoten-mot-var-halsa/ 2020-02-06T19:47:49+00:00 https://dev.intervacc.se/intervacc-har-genomfort-en-riktad-emission-till-institutionella-investerare-om-cirka-62-msek/ 2020-02-06T19:55:26+00:00 https://dev.intervacc.se/intervacc-presenterar-hos-aktiespararna/ 2020-02-06T19:57:04+00:00 https://dev.intervacc.se/valideringssatser-av-strangvac-fardigstallda/ 2020-02-11T21:51:27+00:00 https://dev.intervacc.se/vetenskapligt-mote-om-kvarka/ 2020-02-13T15:14:06+00:00 https://dev.intervacc.se/wp-content/uploads/2019/08/getting-to-grips-2019.jpg https://dev.intervacc.se/bokslutskommunike-2019/ 2020-02-21T07:32:11+00:00 https://dev.intervacc.se/intervacc-ansoker-om-marknadsforingstillstand-for-strangvac-hos-ema/ 2020-02-26T09:25:55+00:00 https://dev.intervacc.se/intervacc-announces-submission-of-the-marketing-authorization-application-for-strangvac-to-ema/ 2020-02-26T09:26:14+00:00 https://dev.intervacc.se/sr-p4-inslag-om-kvarka-och-nytt-vaccin/ 2020-03-10T11:41:12+00:00 https://dev.intervacc.se/wp-content/uploads/2018/11/Jan-Ingmar_Flock_strangvac_sm1.jpg https://dev.intervacc.se/extra-valkommet-vaccin-p4-skaraborg/ 2020-03-18T08:48:34+00:00 https://dev.intervacc.se/wp-content/uploads/2018/11/Jan-Ingmar_Flock_strangvac_sm1.jpg https://dev.intervacc.se/europeiska-lakemedelsmyndigheten-bekraftar-att-intervaccs-ansokan-om-marknadsforingstillstand-for-strangvac-ar-komplett-och-korrekt-inlamnad/ 2020-03-18T23:12:28+00:00 https://dev.intervacc.se/intervacc-medverkar-pa-abgsc-investor-days-den-19-mars/ 2020-03-19T14:59:01+00:00 https://dev.intervacc.se/intervacc-beviljas-medel-fran-vinnova-for-vidareutveckling-av-vaccin-mot-staphylococcus-aureus-infektioner/ 2020-03-25T23:11:20+00:00 https://dev.intervacc.se/intervacc-publicerar-arsredovisning-for-2019/ 2020-04-01T11:31:13+00:00 https://dev.intervacc.se/kallelse-till-arsstamma-i-intervacc-ab-publ-4/ 2020-05-13T10:44:54+00:00 https://dev.intervacc.se/delarsrapport-januari-mars-2020/ 2020-05-14T07:02:46+00:00 https://dev.intervacc.se/andrat-antal-aktier-och-roster-i-intervacc-ab-publ/ 2020-05-25T16:19:40+00:00 https://dev.intervacc.se/positiva-resultat-fran-strangvac-studie-publicerade-i-vetenskapliga-tidskriften-vaccine/ 2020-06-04T06:31:18+00:00 https://dev.intervacc.se/positive-results-from-strangvac-clinical-trials-published-in-scientific-journal-vaccine/ 2020-06-04T07:58:53+00:00 https://dev.intervacc.se/intervacc-rekryterar-internationell-bakteriologi-expert-som-forskningschef/ 2020-06-11T06:31:01+00:00 https://dev.intervacc.se/intervacc-appoints-international-bacteriology-expert-as-chief-scientific-officer/ 2020-06-11T06:31:18+00:00 https://dev.intervacc.se/kommunike-fran-arsstamma-i-intervacc-ab-publ-4/ 2020-06-11T17:19:49+00:00 https://dev.intervacc.se/intervacc-valkomnar-ed-torr-och-niels-holck/ 2020-06-12T07:54:32+00:00 https://dev.intervacc.se/intervacc-tecknar-samarbetsavtal-med-karolinska-institutet-for-vidareutveckling-av-en-ny-generation-vacciner-inom-djurhalsa/ 2020-06-15T07:46:40+00:00 https://dev.intervacc.se/intervacc-and-the-karolinska-institutet-extends-contract-for-the-development-of-innovative-animal-health-vaccines/ 2020-06-15T07:46:58+00:00 https://dev.intervacc.se/intervacc-avser-att-genomfora-en-riktad-nyemission/ 2020-06-16T15:46:12+00:00 https://dev.intervacc.se/intervacc-intends-to-carry-out-a-directed-share-issue/ 2020-06-16T15:48:18+00:00 https://dev.intervacc.se/intervacc-har-genomfort-en-riktad-nyemission-om-cirka-65-miljoner-aktier-och-tillfors-harigenom-cirka-147-miljoner-kronor/ 2020-06-16T22:37:44+00:00 https://dev.intervacc.se/andrat-antal-aktier-och-roster-i-intervacc-ab-publ-2/ 2020-07-07T12:32:20+00:00 https://dev.intervacc.se/delarsrapport-januari-juni-2020/ 2020-08-27T07:05:03+00:00 https://dev.intervacc.se/intervacc-medverkar-pa-abgsc-investor-day-den-7-september/ 2020-09-10T20:49:10+00:00 https://dev.intervacc.se/global-product-manager-for-strangvac/ 2020-10-06T14:52:52+00:00 https://dev.intervacc.se/vi-soker-global-produktchef-for-strangvac/ 2020-10-06T14:53:12+00:00 https://dev.intervacc.se/delarsrapport-januari-september-2020/ 2020-11-12T07:31:38+00:00 https://dev.intervacc.se/interim-report-january-september-2020/ 2020-11-12T07:32:56+00:00 https://dev.intervacc.se/quality-assurance-qa-manager-at-intervacc/ 2020-11-18T17:00:56+00:00 https://dev.intervacc.se/intervacc-rekryterar-emma-hartman-som-produktchef-strangvac/ 2020-11-25T10:38:33+00:00 https://dev.intervacc.se/intervacc-appoints-emma-hartman-as-global-product-manager-for-strangvac/ 2020-11-25T10:39:39+00:00 https://dev.intervacc.se/svaren-pa-120-dagars-fragorna-nu-inlamnade-till-ema/ 2021-01-12T13:45:34+00:00 https://dev.intervacc.se/bokslutskommunike-januari-december-2020/ 2021-02-18T07:31:12+00:00 https://dev.intervacc.se/intervacc-publicerar-arsredovisning-for-2020/ 2021-03-31T06:32:56+00:00 https://dev.intervacc.se/intervacc-publishes-the-2020-annual-report/ 2021-03-31T06:33:07+00:00 https://dev.intervacc.se/intervacc-ab-och-dechra-pharmaceuticals-plc-ingar-avtal-for-kommersialisering-av-strangvac-i-europa/ 2021-04-12T22:41:20+00:00 https://dev.intervacc.se/intervacc-ab-and-dechra-pharmaceuticals-plc-enter-into-an-agreement-to-commercialize-strangvac-in-europe/ 2021-04-12T22:43:50+00:00 https://dev.intervacc.se/notice-of-annual-general-meeting-in-intervacc-ab-publ/ 2021-05-10T13:32:24+00:00 https://dev.intervacc.se/delarsrapport-januari-mars-2021/ 2021-05-21T06:31:54+00:00 https://dev.intervacc.se/wp-content/uploads/2021/05/Andreas-21_300.png https://dev.intervacc.se/wp-content/uploads/2021/05/stoppakvarkan_2021_300.png https://dev.intervacc.se/interim-report-january-march-2021/ 2021-05-21T06:33:05+00:00 https://dev.intervacc.se/wp-content/uploads/2021/05/Andreas-21_300.png https://dev.intervacc.se/wp-content/uploads/2021/05/stoppakvarkan_2021_300.png https://dev.intervacc.se/intervacc-tecknar-flerarigt-samarbetsavtal-med-karolinska-institutet-for-vidareutveckling-av-en-ny-generation-vacciner-inom-djurhalsa/ 2021-05-28T13:03:04+00:00 https://dev.intervacc.se/report-from-annual-general-meeting-in-intervacc/ 2021-06-09T11:33:44+00:00 https://dev.intervacc.se/ceo-presentation-agm/ 2021-06-14T22:30:36+00:00 https://dev.intervacc.se/kallelse-till-arsstamma-i-intervacc-ab-publ-5/ 2021-06-21T22:16:47+00:00 https://dev.intervacc.se/kommunike-fran-arsstamma-i-intervacc-ab-publ-5/ 2021-06-21T22:17:55+00:00 https://dev.intervacc.se/vd-presentation-arsstamma/ 2021-07-20T09:10:44+00:00 https://dev.intervacc.se/vi-soker-kvalitetssakringschef-qa-manager/ 2021-07-20T09:14:44+00:00 https://dev.intervacc.se/intervacc-ab-publ-publicerar-arsredovisning-for-2018/ 2021-07-20T09:16:37+00:00 https://dev.intervacc.se/intervacc-erhaller-postivt-utlatande-for-sitt-kvarkavaccin-strangvac-i-storbritannien/ 2021-07-20T09:21:25+00:00 https://dev.intervacc.se/nytt-distributionsavtal-med-chemvet/ 2021-07-20T09:24:38+00:00 https://dev.intervacc.se/resultat-fran-strangvacs-kliniska-provningar-presenterade-vid-vetenskapligt-mote-om-kvarka/ 2021-07-20T09:26:10+00:00 https://dev.intervacc.se/intervacc-har-presenterat-resultat-fran-kliniska-provningar-vid-weas-2017/ 2021-07-20T09:28:52+00:00 https://dev.intervacc.se/wp-content/uploads/2017/08/WEAS_log.png https://dev.intervacc.se/kommunike-fran-extra-bolagsstamma-intervacc-ab-publ/ 2021-07-20T09:31:43+00:00 https://dev.intervacc.se/intervacc-erhaller-positivt-cvmp-utlatande-for-sitt-kvarkavaccin-strangvac-i-eu/ 2021-07-20T09:36:49+00:00 https://dev.intervacc.se/dna-undersokning-pavisar-en-otyglad-global-spridning-av-kvarkabakterien-hos-hastar/ 2021-07-20T09:41:58+00:00 https://dev.intervacc.se/wp-content/uploads/2021/03/globetrotting-study.jpg https://dev.intervacc.se/tillverkningsprocessen-for-strangvac-gar-vidare-enligt-plan/ 2021-07-20T09:46:13+00:00 https://dev.intervacc.se/intervacc-meddelar-utfall-av-teckning-i-incitamentsprogram-2019-2022/ 2021-07-20T09:48:54+00:00 https://dev.intervacc.se/forhandsmote-med-ema-om-registreringsansokan-for-strangvac-genomfort/ 2021-07-20T09:51:00+00:00 https://dev.intervacc.se/intervacc-abs-foretradesemission-overtecknad/ 2021-07-20T09:57:11+00:00 https://dev.intervacc.se/intervacc-receives-positive-cvmp-opinion-for-strangvac-a-vaccine-against-equine-strangles-in-the-eu/ 2021-07-20T10:03:47+00:00 https://dev.intervacc.se/intervacc-receives-confirmation-of-a-positive-outcome-for-strangvac-a-vaccine-against-equine-strangles-from-the-vmd-in-the-uk/ 2021-07-20T10:06:40+00:00 https://dev.intervacc.se/intervacc-and-the-karolinska-institutet-sign-a-multi-year-contract-for-the-development-of-innovative-animal-health-vaccines/ 2021-07-20T10:10:40+00:00 https://dev.intervacc.se/dna-investigation-highlights-the-unbridled-globetrotting-of-the-strangles-pathogen-in-horses/ 2021-07-20T10:14:31+00:00 https://dev.intervacc.se/wp-content/uploads/2021/03/globetrotting-study-web.jpg https://dev.intervacc.se/intervacc-to-participate-at-abgsc-investor-day-on-september-7/ 2021-07-20T10:16:17+00:00 https://dev.intervacc.se/year-end-report-january-december-2020/ 2021-07-20T10:18:49+00:00 https://dev.intervacc.se/intervacc-awarded-funding-from-vinnova-for-further-development-of-vaccine-against-staphylococcus-aureus-infections/ 2021-07-20T10:20:48+00:00 https://dev.intervacc.se/intervacc-announces-submission-of-responses-to-ema-day-120-questions/ 2021-07-20T10:22:41+00:00 https://dev.intervacc.se/intervacc-expands-the-distribution-agreement-with-animalcare-group-plc/ 2021-07-20T10:25:14+00:00 https://dev.intervacc.se/animal-pharm-writes-strangles-strangvac/ 2021-07-20T10:28:15+00:00 https://dev.intervacc.se/wp-content/uploads/2017/02/animalpharm_logo.jpg https://dev.intervacc.se/the-european-medicines-agency-confirms-that-intervaccs-application-for-the-granting-of-a-community-marketing-authorization-for-strangvac-is-complete-and-correctly-submitted/ 2021-07-20T10:30:23+00:00 https://dev.intervacc.se/intervacc-has-carried-out-a-directed-issue-of-approximately-6-5-million-shares-raising-gross-proceeds-of-approximately-sek-147-million/ 2021-07-20T10:32:41+00:00 https://dev.intervacc.se/large-scale-manufacturing-process-for-strangvac-now-secured/ 2021-07-20T10:34:14+00:00 https://dev.intervacc.se/updated-timetable-for-submission-of-the-application-to-the-european-medicines-agency/ 2021-07-20T10:36:26+00:00 https://dev.intervacc.se/intervacc-has-completed-a-directed-issue-to-institutional-investors-of-approximately-sek-62-million/ 2021-07-20T10:39:06+00:00 https://dev.intervacc.se/strangvac-a-vaccine-against-equine-strangles-has-been-granted-marketing-authorisation-by-the-european-commission/ 2021-08-16T21:09:00+00:00 https://dev.intervacc.se/eu-kommissionen-beviljar-marknadsforingstillstand-for-strangvac-ett-vaccin-mot-kvarka/ 2021-08-16T22:30:08+00:00 https://dev.intervacc.se/strangvac-ett-vaccin-mot-kvarka-har-beviljats-marknadsforingstillstand-i-norge/ 2021-08-23T16:12:04+00:00 https://dev.intervacc.se/strangvac-a-vaccine-against-equine-strangles-has-been-granted-marketing-authorisation-in-norway/ 2021-08-23T16:13:10+00:00 https://dev.intervacc.se/intervacc-brings-forward-the-report-for-the-first-half-of-2021-to-august-31-2021/ 2021-08-25T12:48:22+00:00 https://dev.intervacc.se/intervacc-tidigarelagger-rapporten-for-forsta-halvaret-2021-till-den-31-augusti-2021/ 2021-08-25T12:59:48+00:00 https://dev.intervacc.se/delarsrapport-januari-juni-2021/ 2021-08-31T06:32:19+00:00 https://dev.intervacc.se/interim-report-january-june-2021/ 2021-08-31T06:33:03+00:00 https://dev.intervacc.se/strangvac-ett-vaccin-mot-kvarka-har-beviljats-marknadsforingstillstand-i-storbritannien/ 2021-09-17T14:54:57+00:00 https://dev.intervacc.se/strangvac-a-vaccine-against-equine-strangles-has-been-granted-marketing-authorisation-in-the-uk/ 2021-09-17T15:01:40+00:00 https://dev.intervacc.se/u-s-patent-approval-for-intervaccs-vaccine-against-infections-caused-by-streptococcus-suis/ 2021-11-08T20:50:51+00:00 https://dev.intervacc.se/intervacc-beviljas-patent-i-usa-for-vaccin-mot-infektioner-orsakade-av-streptococcus-suis/ 2021-11-08T20:52:54+00:00 https://dev.intervacc.se/valberedning-utsedd-infor-arsstamma-2022-i-intervacc/ 2021-11-30T14:01:33+00:00 https://dev.intervacc.se/nomination-committee-appointed-in-respect-of-agm-2022-in-intervacc/ 2021-11-30T14:02:15+00:00 https://dev.intervacc.se/forsaljningsstart-for-intervaccs-vaccin-mot-kvarka-under-forsta-kvartalet-2022/ 2021-12-14T15:41:46+00:00 https://dev.intervacc.se/intervacc-kommenterar-handelsstoppet-av-bolagets-aktie-pa-nasdaq-first-north/ 2021-12-15T15:41:43+00:00 https://dev.intervacc.se/intervacc-comments-on-the-trading-halt-of-the-companys-share-on-nasdaq-first-north/ 2021-12-15T18:32:14+00:00 https://dev.intervacc.se/clarification-regarding-intervaccs-vaccine-strangvac/ 2021-12-17T16:17:45+00:00 https://dev.intervacc.se/klargorande-avseende-intervaccs-vaccin-strangvac/ 2021-12-29T14:07:34+00:00 https://dev.intervacc.se/vetenskaplig-studie-visar-att-strangvac-sannolikt-ar-effektivt-mot-alla-kanda-stammar-av-bakterien-som-orsakar-kvarka/ 2022-01-21T10:20:30+00:00 https://dev.intervacc.se/new-study-confirms-that-strangvac-is-likely-to-be-effective-against-all-known-strains-of-streptococcus-equi/ 2022-01-21T11:24:08+00:00 https://dev.intervacc.se/intervacc-har-ansokt-om-tillaggsskydd-for-strangvac-pa-viktiga-europeiska-marknader/ 2022-02-01T07:36:53+00:00 https://dev.intervacc.se/intervacc-has-applied-for-supplementary-protection-certificates-for-strangvac-in-key-european-markets/ 2022-02-01T07:37:38+00:00 https://dev.intervacc.se/sales-launch-of-intervacc-vaccine-against-equine-strangles-during-q1-2022/ 2022-02-09T17:03:37+00:00 https://dev.intervacc.se/intervacc-ansoker-om-marknadsforingstillstand-for-strangvac-i-usa/ 2022-02-16T07:31:10+00:00 https://dev.intervacc.se/intervacc-applies-for-a-permit-for-sale-and-distribution-of-strangvac-in-the-u-s/ 2022-02-16T07:33:43+00:00 https://dev.intervacc.se/year-end-report-january-december-2021/ 2022-02-18T07:31:39+00:00 https://dev.intervacc.se/bokslutskommunike-januari-december-2021/ 2022-02-18T07:31:52+00:00 https://dev.intervacc.se/europeiska-lakemedelsmyndigheten-forlanger-hallbarheten-pa-antigenerna-i-strangvac-till-28-manader/ 2022-03-09T10:25:10+00:00 https://dev.intervacc.se/strangvac-a-vaccine-against-equine-strangles-released-for-sale-in-sweden/ 2022-03-23T16:20:01+00:00 https://dev.intervacc.se/intervacc-publishes-the-2021-annual-report/ 2022-04-06T07:01:30+00:00 https://dev.intervacc.se/intervacc-publicerar-arsredovisning-for-2021/ 2022-04-06T07:10:10+00:00 https://dev.intervacc.se/positiva-resultat-i-proof-of-concept-studie-for-att-utveckla-ett-vaccin-mot-streptococcus-suis-infektion-hos-grisar/ 2022-04-25T11:58:24+00:00 https://dev.intervacc.se/positive-results-in-proof-of-concept-study-to-develop-a-vaccine-against-streptococcus-suis-infection-in-pigs/ 2022-04-25T12:02:24+00:00 https://dev.intervacc.se/norge-andrar-regelverk-och-tillater-vaccination-av-hastar-mot-kvarka/ 2022-05-06T12:10:36+00:00 https://dev.intervacc.se/the-norwegian-food-safety-authority-change-their-regulations-to-allow-vaccination-of-horses-against-equine-strangles/ 2022-05-06T15:03:38+00:00 https://dev.intervacc.se/kallelse-till-arsstamma-i-intervacc-ab-2022/ 2022-05-11T18:57:50+00:00 https://dev.intervacc.se/notice-of-annual-general-meeting-in-intervacc-ab-publ-2/ 2022-05-11T18:58:09+00:00 https://dev.intervacc.se/the-european-medicines-agency-extends-the-shelf-life-of-the-antigens-used-in-strangvac-to-28-months/ 2022-05-16T10:52:57+00:00 https://dev.intervacc.se/intervacc-gor-framsteg-i-vaccinutvecklingen-for-att-forhindra-mastit-hos-mjolkkor-orsakade-av-staphylococcus-aureus/ 2022-05-19T06:03:35+00:00 https://dev.intervacc.se/intervacc-progresses-vaccine-to-prevent-mastitis-in-dairy-cows-caused-by-staphylococcus-aureus/ 2022-05-19T06:05:25+00:00 https://dev.intervacc.se/delarsrapport-januari-mars-2022/ 2022-05-20T06:31:17+00:00 https://dev.intervacc.se/interim-report-january-march-2022/ 2022-05-20T06:31:37+00:00 https://dev.intervacc.se/report-from-annual-general-meeting-in-intervacc-2/ 2022-06-15T06:11:39+00:00 https://dev.intervacc.se/kommunike-fran-arsstamma-i-intervacc-ab-publ-6/ 2022-07-15T09:46:07+00:00 https://dev.intervacc.se/strangvac-ett-vaccin-mot-kvarka-tillgangligt-for-forsaljning-i-danmark/ 2022-07-15T09:46:41+00:00 https://dev.intervacc.se/strangvac-a-vaccine-against-equine-strangles-released-for-sales-in-the-uk/ 2022-07-20T12:18:10+00:00 https://dev.intervacc.se/intervacc-receives-order-for-strangvac-a-vaccine-against-the-equine-disease-strangles-from-the-dechra-pharmaceuticals-plc-group-for-launch-in-selected-european-countries/ 2022-07-20T12:37:13+00:00 https://dev.intervacc.se/vd-och-ett-antal-nyckelpersoner-tecknar-aktier-genom-utnyttjande-av-teckningsoptioner-i-intervaccs-incitamentsprogram-2019-2022/ 2022-07-26T18:46:54+00:00 https://dev.intervacc.se/the-ceo-and-a-number-of-key-personnel-acquires-shares-through-the-exercise-of-warrants-in-intervaccs-incentive-program-2019-2022/ 2022-07-26T18:47:19+00:00 https://dev.intervacc.se/strangvac-ett-vaccin-mot-kvarka-frislappt-for-forsaljning-i-storbritannien/ 2022-08-12T13:59:47+00:00 https://dev.intervacc.se/intervacc-far-order-avseende-strangvac-ett-vaccin-mot-kvarka-for-lansering-i-utvalda-europeiska-lander/ 2022-08-12T14:00:44+00:00 https://dev.intervacc.se/strangvac-ett-vaccin-mot-kvarka-frislappt-for-forsaljning-i-sverige/ 2022-08-12T14:04:53+00:00 https://dev.intervacc.se/tillsammans-mot-kvarka/ 2022-08-12T14:30:27+00:00 https://dev.intervacc.se/forsaljningsstart-i-storbritannien-for-strangvac-ett-vaccin-mot-kvarka/ 2022-08-17T11:03:46+00:00 https://dev.intervacc.se/strangvac-a-vaccine-against-equine-strangles-is-now-available-for-sale-in-the-uk/ 2022-08-17T11:04:08+00:00 https://dev.intervacc.se/strangvac-a-vaccine-against-equine-strangles-available-for-sale-in-denmark/ 2022-08-22T12:44:50+00:00 https://dev.intervacc.se/interim-report-january-june-2022/ 2022-08-31T06:31:18+00:00 https://dev.intervacc.se/delarsrapport-januari-juni-2022/ 2022-08-31T07:11:38+00:00 https://dev.intervacc.se/strangvac-ett-vaccin-mot-kvarka-frislappt-for-forsaljning-i-tyskland-frankrike-osterrike-och-benelux/ 2022-10-12T11:32:43+00:00 https://dev.intervacc.se/strangvac-a-vaccine-against-equine-strangles-released-for-sales-in-germany-france-austria-and-the-benelux/ 2022-10-12T11:33:05+00:00 https://dev.intervacc.se/interim-report-january-september-2021/ 2022-11-09T14:42:50+00:00 https://dev.intervacc.se/delarsrapport-januari-september-2021/ 2022-11-09T14:45:05+00:00 https://dev.intervacc.se/delarsrapport-januari-september-2022/ 2022-11-10T07:33:00+00:00 https://dev.intervacc.se/interim-report-january-september-2022/ 2022-11-10T07:33:41+00:00 https://dev.intervacc.se/nomination-committee-appointed-in-respect-of-agm-2023-in-intervacc/ 2022-11-11T15:01:23+00:00 https://dev.intervacc.se/valberedning-utsedd-infor-arsstamma-2023-i-intervacc/ 2022-11-11T15:01:38+00:00 https://dev.intervacc.se/intervaccs-chief-scientific-officer-dr-andrew-waller-forelaser-om-kvarka-pa-london-vet-show/ 2022-11-16T06:31:34+00:00 https://dev.intervacc.se/intervaccs-chief-scientific-officer-dr-andrew-waller-will-speak-about-the-prevention-of-equine-strangles-at-the-london-vet-show/ 2022-11-16T06:32:04+00:00 https://dev.intervacc.se/intervaccs-chief-scientific-officer-dr-andrew-waller-participate-at-the-dutch-equine-conference/ 2022-11-24T17:02:46+00:00 https://dev.intervacc.se/intervaccs-chief-scientific-officer-dr-andrew-waller-medverkar-pa-dutch-equine-conference/ 2022-11-24T17:03:05+00:00 https://dev.intervacc.se/forsaljningsstart-for-strangvac-i-irland/ 2022-11-27T23:18:50+00:00 https://dev.intervacc.se/forsaljningsstart-i-polen-for-strangvac-ett-vaccin-mot-kvarka/ 2022-11-28T10:46:53+00:00 https://dev.intervacc.se/strangvac-a-vaccine-against-equine-strangles-is-now-available-for-sale-in-poland/ 2022-11-28T10:47:31+00:00 https://dev.intervacc.se/strangvac-ett-vaccin-mot-kvarka-frislappt-for-forsaljning-i-italien/ 2022-12-13T12:31:25+00:00 https://dev.intervacc.se/strangvac-a-vaccine-against-equine-strangles-released-for-sales-in-italy/ 2022-12-13T12:31:41+00:00 https://dev.intervacc.se/intervacc-och-sveriges-lantbruksuniversitet-slu-fornyar-flerarigt-samarbetsavtal-for-vidareutveckling-av-vacciner-inom-djurhalsa/ 2022-12-19T15:02:15+00:00 https://dev.intervacc.se/intervacc-and-the-swedish-university-of-agricultural-sciences-slu-extends-a-multi-year-contract-for-the-development-of-innovative-animal-health-vaccines/ 2022-12-19T15:02:36+00:00 https://dev.intervacc.se/intervaccs-forskningschef-dr-andrew-waller-presenterar-pa-veterinary-sport-horse-congress-i-amsterdam/ 2023-01-23T14:46:16+00:00 https://dev.intervacc.se/intervaccs-chief-scientific-officer-dr-andrew-waller-presents-at-the-veterinary-sport-horse-congress-in-amsterdam/ 2023-01-23T15:12:20+00:00 https://dev.intervacc.se/intervaccs-chief-scientific-officer-dr-andrew-waller-presents-at-the-feeva-european-horse-welfare-symposium-in-amsterdam/ 2023-01-24T12:02:19+00:00 https://dev.intervacc.se/intervaccs-forskningschef-dr-andrew-waller-presenterar-pa-feeva-european-horse-welfare-symposium-i-amsterdam/ 2023-01-24T12:02:34+00:00 https://dev.intervacc.se/fortydligande-angaende-insynsforsaljning-i-intervacc-ab-publ/ 2023-02-22T18:41:47+00:00 https://dev.intervacc.se/bokslutskommunike-januari-december-2022/ 2023-02-24T16:46:56+00:00 https://dev.intervacc.se/year-end-report-january-december-2022/ 2023-02-24T16:48:05+00:00 https://dev.intervacc.se/intervacc-publicerar-arsredovisning-for-2022/ 2023-04-06T06:31:38+00:00 https://dev.intervacc.se/intervacc-publishes-the-2022-annual-report/ 2023-04-06T06:32:00+00:00 https://dev.intervacc.se/the-board-of-directors-in-intervacc-intends-to-resolve-on-a-fully-covered-rights-issue-of-approximately-sek-100-million/ 2023-04-19T06:02:45+00:00 https://dev.intervacc.se/kallelse-till-extra-bolagsstamma-i-intervacc-ab-publ-2/ 2023-04-19T12:37:34+00:00 https://dev.intervacc.se/styrelsen-i-intervacc-avser-att-besluta-om-en-fullt-sakerstalld-foretradesemission-om-cirka-100-miljoner-kronor/ 2023-04-19T12:39:31+00:00 https://dev.intervacc.se/notice-of-extraordinary-general-meeting-in-intervacc-ab-publ/ 2023-04-19T14:04:07+00:00 https://dev.intervacc.se/report-from-extraordinary-general-meeting-in-intervacc/ 2023-05-05T11:41:26+00:00 https://dev.intervacc.se/kommunike-fran-extra-bolagsstamma-i-intervacc-ab-publ-3/ 2023-05-05T15:00:33+00:00 https://dev.intervacc.se/kallelse-till-arsstamma-i-intervacc-ab-publ-6/ 2023-05-05T22:17:27+00:00 https://dev.intervacc.se/interim-report-january-march-2023/ 2023-05-05T22:18:26+00:00 https://dev.intervacc.se/veterinary-medicines-directorate-vmd-forlanger-hallbarheten-for-strangvac-ett-vaccin-mot-kvarka-till-33-manader-i-storbritannien/ 2023-05-08T13:02:35+00:00 https://dev.intervacc.se/veterinary-medicines-directorate-vmd-extends-the-shelf-life-for-strangvac-a-vaccine-against-equine-strangles-to-33-months/ 2023-05-08T13:03:25+00:00 https://dev.intervacc.se/rattelse-kallelse-till-arsstamma-i-intervacc-ab-publ/ 2023-05-10T19:11:29+00:00 https://dev.intervacc.se/styrelsen-i-intervacc-har-beslutat-om-en-fullt-sakerstalld-foretradesemission-om-cirka-100-miljoner-kronor/ 2023-05-12T10:39:43+00:00 https://dev.intervacc.se/the-board-of-directors-in-intervacc-has-resolved-on-a-fully-covered-rights-issue-of-approximately-sek-104-million/ 2023-05-12T10:40:23+00:00 https://dev.intervacc.se/europeiska-lakemedelsmyndigheten-ema-godkanner-forlangning-av-hallbarheten-for-strangvac-ett-vaccin-mot-kvarka-till-33-manader/ 2023-05-17T13:24:01+00:00 https://dev.intervacc.se/intervacc-ab-publ-publishes-prospectus-in-connection-with-a-fully-covered-rights-issue/ 2023-05-23T07:54:41+00:00 https://dev.intervacc.se/notice-of-annual-general-meeting-in-intervacc-ab-publ-3/ 2023-05-26T08:47:37+00:00 https://dev.intervacc.se/correction-notice-of-annual-general-meeting-in-intervacc-ab-publ/ 2023-05-26T08:48:34+00:00 https://dev.intervacc.se/the-european-medicines-agency-ema-approves-extention-of-shelf-life-for-strangvac-a-vaccine-against-equine-strangles-to-33-months/ 2023-05-29T07:47:42+00:00 https://dev.intervacc.se/report-from-annual-general-meeting-in-intervacc-3/ 2023-06-07T18:44:13+00:00 https://dev.intervacc.se/kommunike-fran-arsstamman-i-intervacc-ab-publ/ 2023-06-08T08:30:08+00:00 https://dev.intervacc.se/intervacc-announces-the-outcome-of-the-fully-secured-rights-issue/ 2023-06-08T18:06:02+00:00 https://dev.intervacc.se/intervacc-staller-ut-pa-falsterbo-horse-show/ 2023-07-10T11:01:26+00:00 https://dev.intervacc.se/intervaccs-beviljas-medel-for-uppstartsfasen-i-ett-utvecklingsprojekt-som-avser-att-ta-fram-tillverkningsprocesser-for-ett-prototypvaccin-mot-streptococcus-suis-infektioner-hos-gris/ 2023-07-11T07:33:45+00:00 https://dev.intervacc.se/intervacc-beviljas-bidrag-for-att-utveckla-tillverkningsprocessen-for-ett-prototypvaccin-for-grisar/ 2023-08-17T13:10:43+00:00 https://dev.intervacc.se/intervacc-awarded-grant-to-optimise-production-processes-for-a-fusion-protein-which-is-one-component-of-a-prototype-vaccine-for-pigs/ 2023-08-17T13:10:56+00:00 https://dev.intervacc.se/andreas-andersson-steps-down-as-president-and-ceo-jonas-sohlman-has-been-appointed-acting-president-and-ceo-for-intervacc/ 2023-08-21T06:34:23+00:00 https://dev.intervacc.se/andreas-andersson-slutar-som-vd-och-koncernchef-jonas-sohlman-har-utsetts-som-tillforordnad-vd-och-koncernchef-for-intervacc/ 2023-08-21T08:26:56+00:00 https://dev.intervacc.se/intervacc-to-collaborate-with-testa-center-to-optimise-production-processes-for-their-prototype-vaccine-for-pigs/ 2023-08-25T15:45:25+00:00 https://dev.intervacc.se/intervacc-valkomnar-agneta-gustafsson/ 2023-09-12T15:54:17+00:00 https://dev.intervacc.se/wp-content/uploads/2023/09/Agneta-Gustafsson-DVM_lr.jpg https://dev.intervacc.se/agneta-gustafsson-joins-intervacc/ 2023-09-12T16:58:23+00:00 https://dev.intervacc.se/wp-content/uploads/2023/09/Agneta-Gustafsson-DVM_lr.jpg https://dev.intervacc.se/delarsrapport-januari-juni-2023/ 2023-09-25T11:03:01+00:00 https://dev.intervacc.se/delarsrapport-januari-mars-2023/ 2023-09-25T21:51:18+00:00 https://dev.intervacc.se/interim-report-january-june-2023/ 2023-10-10T15:34:43+00:00 https://dev.intervacc.se/kallelse-till-extra-bolagsstamma-i-intervacc-ab-publ-3/ 2023-10-19T16:56:25+00:00 https://dev.intervacc.se/notice-of-extraordinary-general-meeting-in-intervacc-ab-publ-2/ 2023-10-19T16:57:16+00:00 https://dev.intervacc.se/valberedning-utsedd-i-intervacc/ 2023-10-30T18:48:34+00:00 https://dev.intervacc.se/nomination-committee-appointed-in-intervacc/ 2023-10-30T18:48:52+00:00 https://dev.intervacc.se/intervacc-ab-publ-offentliggor-prospekt-i-samband-med-fullt-sakerstalld-foretradesemission/ 2023-11-15T15:17:12+00:00 https://dev.intervacc.se/intervacc-offentliggor-utfall-i-den-fullt-sakerstallda-foretradesemissionen/ 2023-11-15T15:18:03+00:00 https://dev.intervacc.se/inbjudan-till-webcast-i-samband-med-intervaccs-delarsrapport-for-tredje-kvartalet-2023/ 2023-11-15T18:21:14+00:00 https://dev.intervacc.se/invitation-to-conference-call-with-presentation-of-intervaccs-interim-report-for-the-third-quarter-2023/ 2023-11-15T18:22:08+00:00 https://dev.intervacc.se/interim-report-january-september-2023/ 2023-11-16T07:31:18+00:00 https://dev.intervacc.se/u-s-patent-approval-for-intervaccs-vaccine-against-infections-caused-by-streptococcus-suis-2/ 2023-11-22T17:17:25+00:00 https://dev.intervacc.se/strangvac-sales-to-start-in-ireland/ 2023-11-22T17:43:12+00:00 https://dev.intervacc.se/intervacc-beviljas-patent-i-usa-for-vaccin-mot-infektioner-orsakade-av-streptococcus-suis-2/ 2023-11-22T18:33:18+00:00 https://dev.intervacc.se/kommunike-fran-extra-bolagsstamma-i-intervacc/ 2023-11-23T15:49:10+00:00 https://dev.intervacc.se/report-from-extraordinary-general-meeting-in-intervacc-2/ 2023-11-23T15:52:48+00:00 https://dev.intervacc.se/europas-ledande-experter-inom-kvarka-traffas-vid-riksanlaggningen-i-flyinge-for-att-dela-de-senaste-framstegen-kring-smittskydd-och-vaccination/ 2023-12-11T09:31:21+00:00 https://dev.intervacc.se/the-national-equestrian-centre-at-flyinge-to-host-european-expert-meeting-on-the-use-of-vaccination-to-prevent-strangles-in-horses/ 2023-12-11T09:31:39+00:00 https://dev.intervacc.se/forandringar-av-valberedningen-i-intervacc/ 2023-12-21T07:32:14+00:00 https://dev.intervacc.se/intervacc-announces-changes-in-the-nomination-committee/ 2023-12-21T07:33:12+00:00 https://dev.intervacc.se/intervaccs-tilldelas-prestigefullt-bidrag-fran-eurostars-for-vidareutveckling-av-sitt-prototypvaccin-till-gris/ 2024-02-07T19:08:57+00:00 https://dev.intervacc.se/intervacc-awarded-prestigious-eurostars-grant-to-advance-their-new-prototype-vaccine-against-streptococcus-suis-infection-in-pigs/ 2024-02-07T19:14:28+00:00 https://dev.intervacc.se/inbjudan-till-telefonkonferens-och-audiocast-i-samband-med-bokslutskommunike/ 2024-02-13T12:01:49+00:00 https://dev.intervacc.se/invitation-to-conference-call-and-audiocast-in-connection-with-the-year-end-report/ 2024-02-13T12:02:15+00:00 https://dev.intervacc.se/bokslutskommunike-januari-december-2023/ 2024-02-21T12:03:48+00:00 https://dev.intervacc.se/intervacc-tidigarelagger-arsstamma-och-rapport-for-forsta-kvartalet-2024/ 2024-02-22T13:31:00+00:00 https://dev.intervacc.se/intervacc-announces-changes-in-dates-for-agm-and-report-for-the-first-quarter-2024/ 2024-02-22T13:31:13+00:00 https://dev.intervacc.se/jonas-sohlman-appointed-as-new-ceo-for-intervacc/ 2024-02-28T07:58:26+00:00 https://dev.intervacc.se/intervacc-offentliggor-forandringar-i-valberedningen/ 2024-03-04T14:31:12+00:00 https://dev.intervacc.se/intervacc-announces-changes-in-the-nomination-committee-2/ 2024-03-04T14:31:38+00:00 https://dev.intervacc.se/intervacc-publishes-the-2023-annual-report/ 2024-04-10T06:31:59+00:00 https://dev.intervacc.se/intervacc-publicerar-arsredovisning-for-2023/ 2024-04-10T06:34:11+00:00 https://dev.intervacc.se/notice-of-annual-general-meeting-in-intervacc-ab-publ-4/ 2024-04-16T14:34:12+00:00 https://dev.intervacc.se/kallelse-till-arsstamma-i-intervacc-ab-publ-7/ 2024-04-16T16:28:07+00:00 https://dev.intervacc.se/year-end-report-january-december-2023/ 2024-05-15T00:12:22+00:00 https://dev.intervacc.se/interim-report-january-march-2024/ 2024-05-15T06:31:24+00:00 https://dev.intervacc.se/delarsrapport-januari-mars-2024/ 2024-05-15T07:14:35+00:00 https://dev.intervacc.se/jonas-sohlman-ny-vd-for-intervacc-ab/ 2024-05-15T07:14:47+00:00 https://dev.intervacc.se/report-from-annual-general-meeting-in-intervacc-4/ 2024-05-15T12:35:55+00:00 https://dev.intervacc.se/kommunike-fran-arsstamman-i-intervacc-ab-publ-2/ 2024-05-21T18:27:36+00:00 https://dev.intervacc.se/intervacc-har-presenterat-nya-ron-pa-acvim-forum-i-usa/ 2024-06-13T09:34:51+00:00 https://dev.intervacc.se/intervacc-has-presented-new-findings-at-the-acvim-forum-in-the-united-states/ 2024-06-13T09:37:18+00:00 https://dev.intervacc.se/minskning-av-aktiekapitalet-registrerat-av-bolagsverket/ 2024-07-31T08:01:24+00:00 https://dev.intervacc.se/reduction-of-share-capital-registered-by-the-swedish-companies-registration-office/ 2024-07-31T08:01:56+00:00 https://dev.intervacc.se/intervacc-forlanger-samarbetsavtal-med-karolinska-institutet-for-vidareutveckling-av-en-ny-generation-vacciner-inom-djurhalsa/ 2024-08-15T07:31:39+00:00 https://dev.intervacc.se/intervacc-and-the-karolinska-institutet-extends-contract-for-the-development-of-innovative-animal-health-vaccines-2/ 2024-08-15T07:32:10+00:00 https://dev.intervacc.se/delarsrapport-januari-juni-2024/ 2024-08-29T06:31:39+00:00 https://dev.intervacc.se/interim-report-january-june-2024/ 2024-08-29T06:32:17+00:00 https://dev.intervacc.se/delarsrapport-januari-september-2023/ 2024-08-30T09:24:54+00:00 https://dev.intervacc.se/forlangt-patentskydd-for-strangvac-i-storbritannien/ 2024-09-20T06:40:22+00:00 https://dev.intervacc.se/extended-patent-protection-for-strangvac-approved-in-the-united-kingdom/ 2024-09-20T06:52:00+00:00 https://dev.intervacc.se/intervacc-bedomer-kortare-restsituation-avseende-strangvac/ 2024-09-20T15:38:54+00:00 https://dev.intervacc.se/intervacc-identifies-a-potential-short-out-of-stock-situation-regarding-strangvac/ 2024-09-20T15:39:27+00:00 https://dev.intervacc.se/out-of-stock-situation-regarding-strangvac-in-sweden-resolved/ 2024-10-21T14:17:53+00:00 https://dev.intervacc.se/restsituationen-avseende-vaccinet-strangvac-i-sverige-ar-lost/ 2024-10-21T14:19:31+00:00 https://dev.intervacc.se/inbjudan-till-telefonkonferens-och-audiocast-i-samband-med-delarsrapport/ 2024-11-11T14:45:53+00:00 https://dev.intervacc.se/invitation-to-conference-call-and-audiocast-in-connection-with-the-interim-report/ 2024-11-11T14:46:10+00:00 https://dev.intervacc.se/delarsrapport-januari-september-2024/ 2024-11-14T07:30:49+00:00 https://dev.intervacc.se/interim-report-january-september-2024/ 2024-12-03T11:00:56+00:00 https://dev.intervacc.se/strangvac-is-back-in-stock-on-all-launched-markets/ 2024-12-06T11:47:04+00:00 https://dev.intervacc.se/strangvac-finns-ater-i-lager-pa-samtliga-lanserade-marknader/ 2024-12-06T11:48:37+00:00 https://dev.intervacc.se/the-board-of-directors-of-intervacc-resolves-on-a-rights-issue-of-approximately-sek-225-million/ 2024-12-19T07:01:59+00:00 https://dev.intervacc.se/styrelsen-for-intervacc-beslutar-om-en-foretradesemission-om-cirka-225-miljoner-kronor/ 2024-12-20T10:27:03+00:00 https://dev.intervacc.se/intervacc-har-erhallit-orders-fran-dechra-pharmaceuticals-med-ett-ordervarde-motsvarande-ca-58-miljoner-kronor/ 2025-01-16T09:32:43+00:00 https://dev.intervacc.se/intervacc-has-received-orders-from-dechra-pharmaceuticals-with-an-order-value-equivalent-to-approximately-sek-5-8-million/ 2025-01-16T09:34:14+00:00 https://dev.intervacc.se/kallelse-till-extra-bolagsstamma-i-intervacc-ab-publ-4/ 2025-01-21T10:23:28+00:00 https://dev.intervacc.se/notice-of-extraordinary-general-meeting-in-intervacc-ab-publ-3/ 2025-01-21T10:23:56+00:00 https://dev.intervacc.se/kommunike-fran-extra-bolagsstamma-i-intervacc-2/ 2025-01-31T14:46:55+00:00 https://dev.intervacc.se/report-from-extraordinary-general-meeting-in-intervacc-3/ 2025-01-31T14:47:35+00:00 https://dev.intervacc.se/intervacc-ab-publ-offentliggor-prospekt-avseende-foretradesemission/ 2025-02-05T14:22:07+00:00 https://dev.intervacc.se/intervacc-ab-publ-publishes-prospectus-regarding-the-rights-issue/ 2025-02-05T14:23:45+00:00 https://dev.intervacc.se/bokslutskommunike-januari-december-2024/ 2025-02-13T07:30:47+00:00 https://dev.intervacc.se/year-end-report-january-december-2024/ 2025-02-13T07:31:13+00:00 https://dev.intervacc.se/intervacc-ab-publ-publishes-supplement-to-the-prospectus-regarding-the-rights-issue/ 2025-02-13T14:01:18+00:00 https://dev.intervacc.se/intervaccs-variationsansokan-godkand-av-europeiska-lakemedelsmyndigheten/ 2025-02-13T17:45:23+00:00 https://dev.intervacc.se/intervaccs-variation-application-approved-by-european-medicines-agency/ 2025-02-13T17:45:31+00:00 https://dev.intervacc.se/intervacc-ab-publ-offentliggor-tillagg-till-prospekt-avseende-foretradesemission/ 2025-02-17T09:15:09+00:00 https://dev.intervacc.se/intervacc-offentliggor-utfall-i-foretradesemissionen/ 2025-02-24T18:56:08+00:00 https://dev.intervacc.se/intervacc-announces-the-outcome-of-the-rights-issue/ 2025-02-24T18:56:36+00:00 https://dev.intervacc.se/intervacc-offentliggor-forandringar-i-valberedningen-2/ 2025-03-17T16:40:45+00:00 https://dev.intervacc.se/intervacc-announces-changes-in-the-nomination-committee-3/ 2025-03-17T16:41:11+00:00 https://dev.intervacc.se/intervaccs-variationsansokan-godkand-av-brittiska-lakemedelsmyndigheten/ 2025-03-28T14:20:23+00:00 https://dev.intervacc.se/intervaccs-variation-application-approved-by-vmd/ 2025-03-28T14:20:43+00:00 https://dev.intervacc.se/intervacc-publicerar-arsredovisning-for-2024/ 2025-04-04T06:34:33+00:00 https://dev.intervacc.se/intervacc-publishes-the-2024-annual-report/ 2025-04-07T10:06:58+00:00 https://dev.intervacc.se/notice-of-annual-general-meeting-in-intervacc-ab-publ-5/ 2025-04-11T13:31:32+00:00 https://dev.intervacc.se/article-on-intervaccs-streptococcus-suis-study-published-in-the-journal-vaccine/ 2025-04-16T07:46:29+00:00 https://dev.intervacc.se/artikel-om-intervaccs-streptococcus-suis-studie-publicerad-i-tidskriften-vaccine/ 2025-04-16T20:56:29+00:00 https://dev.intervacc.se/kallelse-till-arsstamma-i-intervacc-ab-publ-8/ 2025-04-22T09:37:41+00:00 https://dev.intervacc.se/intervaccs-distributionspartner-dechra-lanserar-strangvac-i-finland/ 2025-05-05T11:15:56+00:00 https://dev.intervacc.se/intervaccs-distribution-partner-dechra-launches-strangvac-in-finland/ 2025-05-05T11:16:16+00:00 https://dev.intervacc.se/delarsrapport-januari-mars-2025/ 2025-05-14T06:30:55+00:00 https://dev.intervacc.se/interim-report-january-march-2025/ 2025-05-14T06:39:57+00:00 https://dev.intervacc.se/kommunike-fran-arsstamman-i-intervacc-ab-publ-3/ 2025-05-21T14:32:29+00:00 https://dev.intervacc.se/report-from-annual-general-meeting-in-intervacc-5/ 2025-05-21T14:33:30+00:00 https://dev.intervacc.se/intervaccs-distributionspartner-dechra-lanserar-strangvac-i-spanien-portugal-och-slovenien/ 2025-08-18T11:03:23+00:00 https://dev.intervacc.se/intervaccs-distribution-partner-dechra-launches-strangvac-in-spain-portugal-and-slovenia/ 2025-08-26T10:36:34+00:00 https://dev.intervacc.se/delarsrapport-januari-juni-2025/ 2025-08-29T06:31:19+00:00 https://dev.intervacc.se/interim-report-january-june-2025/ 2025-08-29T06:31:42+00:00 https://dev.intervacc.se/intervacc-rekryterar-anna-carin-lagerlof-som-forsaljnings-och-marknadschef/ 2025-09-25T06:30:46+00:00 https://dev.intervacc.se/intervacc-appoints-anna-carin-lagerlof-as-sales-and-marketing-director/ 2025-09-25T06:31:00+00:00 https://dev.intervacc.se/intervacc-och-dechra-forlanger-distributionsavtalet-avseende-intervaccs-kvarkavaccin-strangvac-med-2-ar/ 2025-10-13T06:23:09+00:00 https://dev.intervacc.se/intervacc-and-dechra-extend-distribution-agreement-for-intervaccs-equine-strangles-vaccine-strangvac-by-two-years/ 2025-10-13T06:23:28+00:00 https://dev.intervacc.se/delarsrapport-januari-september-2025/ 2025-11-19T07:30:51+00:00 https://dev.intervacc.se/interim-report-january-september-2025/ 2025-11-19T07:31:08+00:00 https://dev.intervacc.se/clinical-studies-with-strangvac-have-begun-in-the-u-s-market/ 2025-12-16T07:33:50+00:00 https://dev.intervacc.se/kliniska-studier-med-strangvac-har-inletts-pa-den-amerikanska-marknaden/ 2025-12-16T07:34:21+00:00 https://dev.intervacc.se/intervacc-offentliggor-byte-av-verkstallande-direktor/ 2026-02-05T18:15:40+00:00 https://dev.intervacc.se/intervacc-announces-change-of-ceo/ 2026-02-05T18:15:52+00:00 https://dev.intervacc.se/bokslutskommunike-januari-december-2025/ 2026-02-17T07:30:56+00:00 https://dev.intervacc.se/year-end-report-january-december-2025/ 2026-02-17T07:31:34+00:00 https://dev.intervacc.se/intervacc-presenterar-for-kapitalmarknaden-vid-tre-tillfallen-i-mars/ 2026-03-09T07:31:17+00:00 https://dev.intervacc.se/intervacc-presents-to-the-capital-market-on-three-occasions-in-march/ 2026-03-09T07:31:44+00:00 https://dev.intervacc.se/intervacc-announces-breakthrough-protection-against-streptococcus-suis-infection-in-piglets/ 2026-03-19T22:52:19+00:00 https://dev.intervacc.se/intervacc-meddelar-banbrytande-skydd-mot-streptococcus-suis-infektion-hos-griskultingar/ 2026-03-20T14:52:22+00:00 https://dev.intervacc.se/intervacc-publicerar-arsredovisning-for-2025/ 2026-04-14T06:30:53+00:00 https://dev.intervacc.se/intervacc-publishes-the-2025-annual-report/ 2026-04-14T06:31:11+00:00 https://dev.intervacc.se/notice-of-annual-general-meeting-in-intervacc-ab-publ-6/ 2026-04-15T09:54:47+00:00 https://dev.intervacc.se/banbrytande-beslut-banar-vag-for-lansering-av-strangvac-pa-island/ 2026-04-16T06:30:56+00:00 https://dev.intervacc.se/unprecedented-decision-opens-the-way-for-the-launch-of-strangvac-in-iceland/ 2026-04-16T06:31:59+00:00 https://dev.intervacc.se/kallelse-till-arsstamma-i-intervacc-ab-publ-9/ 2026-04-20T16:43:43+00:00 https://dev.intervacc.se/intervacc-samlar-ledande-experter-fran-usa-och-europa-i-en-gemensam-kamp-mot-kvarka/ 2026-04-23T06:31:43+00:00 https://dev.intervacc.se/intervacc-brings-together-leading-us-and-european-experts-to-jointly-tackle-strangles/ 2026-04-23T06:32:18+00:00 https://dev.intervacc.se/internationell-informationsinsats-mot-kvarka/ 2026-05-05T13:47:57+00:00 https://dev.intervacc.se/international-awareness-initiative-against-strangles/ 2026-05-05T13:48:19+00:00 https://dev.intervacc.se/intervacc-forstarker-ledningsgruppen-for-framtida-tillvaxt/ 2026-05-12T11:00:23+00:00 https://dev.intervacc.se/intervacc-strengthens-management-team-for-future-growth/ 2026-05-12T11:00:36+00:00 https://dev.intervacc.se/delarsrapport-januari-mars-2026/ 2026-05-13T06:30:43+00:00 https://dev.intervacc.se/interim-report-january-march-2026/ 2026-05-13T06:31:04+00:00 https://dev.intervacc.se/report-from-annual-general-meeting-in-intervacc-6/ 2026-05-13T14:15:57+00:00 https://dev.intervacc.se/kommunike-fran-arsstamman-i-intervacc/ 2026-05-14T19:34:19+00:00 https://dev.intervacc.se/emil-billback-appointed-new-chair-of-the-board-of-intervacc/ 2026-05-15T06:31:34+00:00 https://dev.intervacc.se/emil-billback-tilltrader-som-ny-ordforande-i-intervacc/ 2026-05-15T06:32:10+00:00 https://dev.intervacc.se/intervacc-har-framgangsrikt-utvarderat-amerikansk-stam-av-kvarkabakterien-infor-kliniska-studier/ 2026-05-22T06:30:49+00:00 https://dev.intervacc.se/intervacc-completes-successful-evaluation-of-us-strain-of-strangles-pathogen-ahead-of-clinical-trials/ 2026-05-22T06:31:14+00:00 https://dev.intervacc.se/intervacc-exporterar-strangvac-till-nya-zeeland-efter-sarskilt-importgodkannande/ 2026-09-24T16:51:08+00:00 https://dev.intervacc.se/intervacc-ansoker-hos-ema-om-utvidgat-godkannande-for-strangvac-till-att-galla-12-manaders-immunitet/ 2026-09-24T16:53:25+00:00 https://dev.intervacc.se/delarsrapport-januari-juni-2026/ 2026-09-24T17:22:46+00:00